Walleye Capital
RMD icon

Walleye Capital’s ResMed RMD Stock Holding History

Walleye Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$738K Buy
+3,289
New +$820K ﹤0.01% 2350
2025
Q4 		– Sell
-6,415
Closed -$1.64M – 5025
2025
Q3 		$1.76M Buy
6,415
+3,160
+97% +$863K 0.01% 1674
2025
Q2 		$840K Sell
3,255
-196
-6% -$46.8K ﹤0.01% 2188
2025
Q1 		$773K Buy
3,451
+2,891
+516% +$675K ﹤0.01% 2199
2024
Q4 		$128K Sell
560
-25,850
-98% -$6.22M ﹤0.01% 4013
2024
Q3 		$6.45M Buy
+26,410
New +$5.9M 0.01% 989
2024
Q2 		– Sell
-1,100
Closed -$223K – 5938
2024
Q1 		$218K Buy
+1,100
New +$202K ﹤0.01% 3923
2023
Q3 		– Sell
-637
Closed -$115K – 5255
2023
Q2 		$139K Sell
637
-695
-52% -$155K ﹤0.01% 3287
2023
Q1 		$292K Buy
1,332
+145
+12% +$31.5K ﹤0.01% 2150
2022
Q4 		$247K Buy
+1,187
New +$261K ﹤0.01% 1911
2019
Q3 		– Sell
-406
Closed -$53.2K – 2203
2019
Q2 		$50K Buy
+406
New +$45K 0.01% 1383

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Walleye Capital's RMD Position: Q1 2026 in Review

Walleye Capital opened a new position in ResMed (RMD) in Q1 2026: 3,289 shares worth $738K. The stake represents ﹤0.01% of the portfolio and ranks #2350 among its holdings. This is a return to the name: Walleye Capital previously reported a position in RMD as recently as Q3 2025.

Walleye Capital first reported a position in RMD in Q2 2019 and has held it in 11 quarters since. The position peaked at $6.45M in Q3 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Walleye Capital held 3,289 shares of ResMed worth $738K as of Q1 2026.
  • ResMed was a new Walleye Capital position in Q1 2026.
  • ResMed made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2350 holding.
  • Walleye Capital first reported a position in ResMed in Q2 2019 and has held it in 11 quarters since.
  • Walleye Capital's ResMed position peaked at $6.45M in Q3 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.